You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Weapon Payloads for Bulk Chemical and Biological Agent Neutralization

    SBC: Integrated Solutions for Systems, Inc.            Topic: DTRA092012

    Current offensive solutions to neutralize chem/bio agent facilities rely on blast and/or short-burst high-temperature neutralization but have the potential to produce severe collateral damage via agent release. Our team proposes the Dispersed Energetics Coupled for Optimized Neutralization (DECON) Concept, an alternative concept to perform bulk neutralization of agents. The DECON concept can be ...

    SBIR Phase II 2011 Department of DefenseDefense Threat Reduction Agency
  2. Microfluidic High-throughput Platform for Determining Kinetic Constants of Enzyme Variants

    SBC: CFD RESEARCH CORPORATION            Topic: CBD10107

    Current high-throughput platforms rely on labeled substrates that produce detectable spectroscopic signals upon reaction for monitoring enzyme catalytic activity. Add to that the high price tag for these instruments, ranging from several hundred thousand to millions of dollars, and there is a clear need for alternate solutions for a label-free, low-cost, high-throughput enzyme screening platform. ...

    SBIR Phase II 2011 Department of DefenseOffice for Chemical and Biological Defense
  3. Development of an extremely efficient nebulizer for intranasal vaccination

    SBC: CREARE LLC            Topic: N/A

    Extremely Efficient Nebulizer for Intranasal Vaccination. Specifically the nasal delivery device could reduce health care associated infections by providing a needle-free method of delivery of vaccines and therapeutics which are currently delivered by injection with all the attendant risks of transmission of blood borne disease through needle-stick injury and unsafe needle practices. One of the m ...

    SBIR Phase II 2011 Department of Health and Human ServicesCenters for Disease Control and Prevention
  4. Characterization and Mitigation of Radiation Effects in Nonplanar Nano-technology Microelectronics

    SBC: CFD RESEARCH CORPORATION            Topic: DTRA092001

    Future high-performance integrated circuits in DoD satellite systems will require silicon-on-insulator (SOI) and non-planar nano-technology devices, such as MultiGate Field Effect Transistors (MuGFETs) or FinFETs, which can decrease pattern area of logic circuits below 50% of the conventional planar technologies. However, the single-event-effect (SEE) response of non-planar devices and circuits is ...

    SBIR Phase II 2011 Department of DefenseDefense Threat Reduction Agency
  5. Blood Brain Barrier Drug Delivery of Therapeutics for Chemical Warfare Agents

    SBC: IMPEL NEUROPHARMA, INC.            Topic: CBD10109

    Technical Abstract Impel NeuroPharma has developed a novel non-invasive delivery system, the POD device that targets drug to the upper third of the nasal cavity which results in direct and rapid transport of drug to the CNS via the olfactory perineural pathways, effectively bypassing the BBB. In Phase I of this research contract Impel successfully characterized and tested both an aqueous and a ...

    SBIR Phase II 2011 Department of DefenseOffice for Chemical and Biological Defense
  6. A Novel Microfludic Device for Drug Toxicity Studies

    SBC: CFD RESEARCH CORPORATION            Topic: CBD10103

    Current drug discovery and development efforts are severely limited by expensive animal trials and oversimplified in vitro models. Results obtained from in vitro models are not predictive of in vivo toxicity owing to significant difference from the in vivo physiological conditions. In this context, we propose to develop and demonstrate a novel microfluidic device that reproduces the physiological ...

    SBIR Phase II 2011 Department of DefenseOffice for Chemical and Biological Defense
US Flag An Official Website of the United States Government